We are live on ! Find out more
UTMD icon

Utah Medical Products

62 hedge funds and large institutions have $107M invested in Utah Medical Products in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 15

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2% less funds holding

Funds holding: 6362 (-1)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

14% less capital invested

Capital invested by funds: $125M → $107M (-$17.4M)

Holders
62
Holders Change
-1
Holders Change %
-1.59%
% of All Funds
1.8%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
8
Increased
22
Reduced
15
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$20.7M
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$15.5M +$12.7K +250 +0.1%
American Century Companies
3
American Century Companies
Missouri
$14.4M +$2.06M +40,542 +16%
MDCM
4
Morgan Dempsey Capital Management
Wisconsin
$10.7M +$633K +12,458 +6%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$7.36M -$20.3K -400 -0.3%
BFA
6
BlackRock Fund Advisors
California
$4.33M -$194K -3,814 -4%
Renaissance Technologies
7
Renaissance Technologies
New York
$4.28M +$20.3K +400 +0.5%
Vanguard Group
8
Vanguard Group
Pennsylvania
$3.77M +$91.4K +1,800 +2%
Northern Trust
9
Northern Trust
Illinois
$2.65M +$207K +4,068 +8%
BIT
10
BlackRock Institutional Trust
California
$2.3M -$174K -3,427 -7%
State Street
11
State Street
Massachusetts
$2.24M +$15.3K +301 +0.7%
RA
12
Royce & Associates
New York
$2.16M +$10.2K +200 +0.5%
BCM
13
Bridgeway Capital Management
Texas
$1.77M
US Bancorp
14
US Bancorp
Minnesota
$1.62M -$11.7K -230 -0.7%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$1.25M -$22.2K -438 -2%
OCG
16
Opus Capital Group
Ohio
$1.11M +$1.15M +22,700 New
AA
17
Ancora Advisors
Ohio
$1.07M +$307K +6,051 +38%
CIC
18
Crawford Investment Counsel
Georgia
$974K
California Public Employees Retirement System
19
California Public Employees Retirement System
California
$792K
TCIM
20
TIAA CREF Investment Management
New York
$653K -$60K -1,181 -8%
Morgan Stanley
21
Morgan Stanley
New York
$651K +$115K +2,273 +20%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$643K +$20.9K +412 +3%
Natixis Advisors
23
Natixis Advisors
Massachusetts
$582K +$35.8K +704 +6%
BIM
24
BlackRock Investment Management
Delaware
$526K +$17.5K +344 +3%
M&T Bank
25
M&T Bank
New York
$491K +$511K +10,065 New

UTMD Hedge Fund Activity: Q3 2014 in Review

62 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q3 2014, worth a combined $107M — down 14% from $125M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of UTMD and 8 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 22 added.

The largest buyer was American Century Companies, adding an estimated $2.06M. The largest seller was Bares Capital Management, exiting entirely with an estimated $15.6M sold.

  • 62 institutional investors held Utah Medical Products (UTMD) as of Q3 2014, down from 63 in Q2 2014.
  • Funds reported $107M of Utah Medical Products stock for Q3 2014, down 14% quarter-over-quarter.
  • 8 funds opened new Utah Medical Products positions in Q3 2014 and 9 closed out, a net change of -1 holder.
  • The largest Utah Medical Products buyer in Q3 2014 was American Century Companies, an estimated $2.06M added.
  • The largest Utah Medical Products seller in Q3 2014 was Bares Capital Management, an estimated $15.6M sold.

Based on aggregated 13F filings for Q3 2014.